Product Description
Product Name: Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Tablets
Strength: Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg
Form: Oral Tablet
Category: Antiretroviral Combination (INSTI + NRTIs)
Indication: Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Tablets is a fixed-dose, once-daily combination antiretroviral therapy (ART) used for the treatment of HIV-1 infection in adults and adolescents. This single-tablet regimen simplifies treatment by combining three highly effective agents with a favorable safety profile.
